Bill Text: US HB9774 | 2025-2026 | 119th Congress | Introduced

Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.

Sponsorship: Bipartisan Bill

Status: (Introduced) 2026-07-20 - Referred to the House Committee on Energy and Commerce. [HB9774 Detail]

Download: US_Congress-2025-HB9774-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.

LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

IL SB3019 FINANCE-AGRICULTURAL BORROWER
US HB9639 FAIR Credit Act Fostering Accuracy and Integrity in the Reporting of Credit...
IL SB2749 DHS-GAMBLING DISORDERS
MA S3162 To improve outdoor lighting, conserve energy, and increase dark-sky vi...
IL SB2857 VEH CD-FRONT PLATE HOLDER
PA HB2017 In general provisions, further providing for definitions; and, in fees,...
CA SB1383 Housing development: density bonus: incentives or concessions: labor s...
US HB9940 To amend title XIX of the Social Security Act to provide a temporary higher...
NY A11457 Exempts certain property within Manhattan in the city of New York from...
OH SB219 Revise the law governing oil and gas wells
feedback